Literature DB >> 15717488

A method to accurately inject tumor cells into the caudate/putamen nuclei of the mouse brain.

Shinya Yamada1, Vazgen Khankaldyyan, Xiang Bu, Atsushi Suzuki, Ignacio Gonzalez-Gomez, Kouichi Takahashi, J Gordon McComb, Walter E Laug.   

Abstract

OBJECTIVE: To improve currently used techniques to implant tumor cells into the parenchyma of the mouse brain.
MATERIALS AND METHODS: The stereotactic injection of 0.5 to 5 microl of indigo carmine over 5 to 40 minutes into the caudate/putamen nuclei of the mouse was done followed by sacrifice and examination of the brain injection site. 1 microl containing 10(5) U87MG glioma cells were stereotactically implanted into the caudate/ putamen nuclei over 20 minutes. The animals were sacrificed from one hour to 63 days after implantation and the brain examined and tumor size measured.
RESULTS: An injection of 1 microl of indigo carmine over 20 minutes produced a spherical deposit of dye within the caudate/putamen nuclei. Larger volumes of indigo carmine or shorter injection times resulted in dye spreading along the injection tract or into the ventricles or subarachnoid space. Using the results of the dye studies, the same parameters were used to successfully inject and confine the glioma cells to the caudate/putamen nuclei in 30 of 32 mice. No tumor was found in 2 animals and appears to be explained by obstruction of the injection cannula. The tumor cells appeared viable an hour after injection. However by day three, considerable necrosis of tumor cells were noted, the effects of which resolved by day five. On day six, the injection site was comparable to that at one hour. In the early phase, until the fifth week, tumor volume doubling time was ten days while afterward it was only five days.
CONCLUSION: The technique described allows the highly accurate and reproducible introduction of a given number of cells into a specific area of the mouse brain. This should reduce the intragroup variability, be it control or therapeutic, allowing better assessment of outcome with fewer number of mice.

Entities:  

Mesh:

Year:  2004        PMID: 15717488

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  10 in total

1.  Novel cell lines established from pediatric brain tumors.

Authors:  Jingying Xu; Anat Erdreich-Epstein; Ignacio Gonzalez-Gomez; Elizabeth Y Melendez; Goar Smbatyan; Rex A Moats; Michael Rosol; Jaclyn A Biegel; C Patrick Reynolds
Journal:  J Neurooncol       Date:  2011-11-27       Impact factor: 4.130

Review 2.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

3.  Creating anatomically accurate and reproducible intracranial xenografts of human brain tumors.

Authors:  Angela M Pierce; Amy K Keating
Journal:  J Vis Exp       Date:  2014-09-24       Impact factor: 1.355

4.  Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar.

Authors:  Xi Feng Fei; Quan Bin Zhang; Jun Dong; Yi Diao; Zhi Min Wang; Ru Jun Li; Zi Cheng Wu; Ai Dong Wang; Qing Lan; Shi Ming Zhang; Qiang Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-06-29

5.  Hyperthermia and chemotherapy using Fe(Salen) nanoparticles might impact glioblastoma treatment.

Authors:  Makoto Ohtake; Masanari Umemura; Itaru Sato; Taisuke Akimoto; Kayoko Oda; Akane Nagasako; Jeong-Hwan Kim; Takayuki Fujita; Utako Yokoyama; Tomohiro Nakayama; Yujiro Hoshino; Mai Ishiba; Susumu Tokura; Masakazu Hara; Tomoya Muramoto; Sotoshi Yamada; Takatsugu Masuda; Ichio Aoki; Yasushi Takemura; Hidetoshi Murata; Haruki Eguchi; Nobutaka Kawahara; Yoshihiro Ishikawa
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

6.  KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.

Authors:  Jie Li; Qian Liu; Zihao Liu; Qian Xia; Zihao Zhang; Rui Zhang; Taihong Gao; Guangyan Gu; Yanan Wang; Dan Wang; Xiuyang Chen; Yihang Yang; Dong He; Tao Xin
Journal:  J Exp Clin Cancer Res       Date:  2018-08-16

7.  Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease.

Authors:  Masahito Kawabori; Aki Tanimori; Shinri Kitta; Hideo Shichinohe; Kiyohiro Houkin
Journal:  Stem Cells Int       Date:  2020-02-11       Impact factor: 5.443

8.  The development of xenograft glioblastoma implants in nude mice brain.

Authors:  F M Brehar; A V Ciurea; Mihaela Chivu; Otilia Zarnescu; R Radulescu; Denisa Dragu
Journal:  J Med Life       Date:  2008 Jul-Sep

9.  Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments.

Authors:  Kyung-Min Kim; Jin-Kyoung Shim; Jong Hee Chang; Ji-Hyun Lee; Se-Hoon Kim; Junjeong Choi; Junseong Park; Eui-Hyun Kim; Sun Ho Kim; Yong-Min Huh; Su-Jae Lee; Jae-Ho Cheong; Seok-Gu Kang
Journal:  Cancer Cell Int       Date:  2016-06-10       Impact factor: 5.722

10.  EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling.

Authors:  Bo Pang; Xiang-Rong Zheng; Jing-Xia Tian; Tai-Hong Gao; Guang-Yan Gu; Rui Zhang; Yi-Bing Fu; Qi Pang; Xin-Gang Li; Qian Liu
Journal:  Oncotarget       Date:  2016-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.